15 Einträge gefunden

1. PTEN loss detection in prostate cancer: comparison of PTEN immunohistochemistry and PTEN FISH in a large retrospective prostatectomy cohort

   1. Lotan, Tamara L
   2. Heumann, Asmus
   3. Rico, Sebastian Dwertmann
   4. Hicks, Jessica
   5. Lecksell, Kristen
   6. Koop, Christina
   7. Sauter, Guido

   2017 - Forschungsinformationssystem des UKE
2. PSMA expression is highly homogenous in primary prostate cancer

   1. Tsourlakis, Maria C
   2. Klein, Franka
   3. Kluth, Martina
   4. Quaas, Alexander
   5. Graefen, Markus
   6. Haese, Alexander
   7. Simon, Ronald

   2015 - Forschungsinformationssystem des UKE
3. Patterns of TPD52 overexpression in multiple human solid tumor types analyzed by quantitative PCR

   1. Tennstedt, Pierre
   2. Bölch, Charlotte
   3. Strobel, Gundula
   4. Minner, Sarah
   5. Burkhardt, Lia
   6. Grob, Tobias
   7. Masser, Sawinee

   2014 - Forschungsinformationssystem des UKE
4. Aberrant presentation of HPA-reactive carbohydrates implies Selectin-independent metastasis formation in human prostate cancer

   1. Lange, Tobias
   2. Kupfernagel, Mareike
   3. Wicklein, Daniel
   4. Gebauer, Florian
   5. Maar, Hanna
   6. Brügge, Kathrin
   7. Müller, Imke

   2014 - Forschungsinformationssystem des UKE
5. High tissue density of FOXP3+ T cells is associated with clinical outcome in prostate cancer

   1. Flammiger, Anna
   2. Weisbach, Lars
   3. Huland, Hartwig
   4. Tennstedt, Pierre
   5. Simon, Ronald
   6. Minner, Sarah
   7. Bokemeyer, Carsten

   2013 - Forschungsinformationssystem des UKE
6. Cysteine-rich secretory protein 3 overexpression is linked to a subset of PTEN-deleted ERG fusion-positive prostate cancers with early biochemical recurrence.

   1. Grupp, Katharina
   2. Kohl, Sebastian
   3. Sirma, Hüseyin
   4. Simon, Ronald
   5. Steurer, Stefan
   6. Becker, Andreas
   7. Adam, Meike

   2013 - Forschungsinformationssystem des UKE
7. Overexpression of the chromatin remodeler death-domain-associated protein in prostate cancer is an independent predictor of early prostate-specific antigen recurrence

   1. Tsourlakis, Maria Christina
   2. Schoop, Michael
   3. Plaß, Christoph
   4. Huland, Hartwig
   5. Graefen, Markus
   6. Steuber, Thomas
   7. Schlomm, Thorsten

   2013 - Forschungsinformationssystem des UKE
8. Loss of pSer2448-mTOR expression is linked to adverse prognosis and tumor progression in ERG-fusion-positive cancers.

   1. Müller, Juliane
   2. Ehlers, Arne
   3. Burkhardt, Lia
   4. Sirma, Hüseyin
   5. Steuber, Thomas
   6. Graefen, Markus
   7. Sauter, Guido

   2013 - Forschungsinformationssystem des UKE
9. High c-MET expression is frequent but not associated with early PSA recurrence in prostate cancer.

   1. Jacobsen, Frank
   2. Ashtiani, Sharad Nouraie
   3. Tennstedt, Pierre
   4. Heinzer, Hans
   5. Simon, Ronald
   6. Sauter, Guido
   7. Sirma, Hüseyin

   2013 - Forschungsinformationssystem des UKE
10. Strong expression of the neuronal transcription factor FOXP2 is linked to an increased risk of early PSA recurrence in ERG fusion-negative cancers.

    1. Stumm, Laura
    2. Burkhardt, Lia
    3. Steurer, Stefan
    4. Simon, Ronald
    5. Adam, Meike
    6. Becker, Andreas
    7. Sauter, Guido

    2013 - Forschungsinformationssystem des UKE
11. Y chromosome losses are exceedingly rare in prostate cancer and unrelated to patient age.

    1. Stahl, Phillip
    2. Kilgué, Adisa
    3. Tennstedt, Pierre
    4. Minner, Sarah Jane Pauline
    5. Krohn, Antje
    6. Simon, Ronald
    7. Krause, Geske

    2012 - Forschungsinformationssystem des UKE
12. Immunological microenvironment in prostate cancer: high mast cell densities are associated with favorable tumor characteristics and good prognosis.

    1. Fleischmann, Achim
    2. Schlomm, Thorsten
    3. Köllermann, Jens
    4. Sekulic, Nikolina
    5. Huland, Hartwig
    6. Mirlacher, Martina
    7. Sauter, Guido

    2009 - Forschungsinformationssystem des UKE
13. Distinct subcellular expression patterns of neutral endopeptidase (CD10) in prostate cancer predict diverging clinical courses in surgically treated patients.

    1. Fleischmann, Achim
    2. Schlomm, Thorsten
    3. Huland, Hartwig
    4. Köllermann, Jens
    5. Simon, Philipp
    6. Mirlacher, Martina
    7. Salomon, Georg

    2008 - Forschungsinformationssystem des UKE
14. Expression and prognostic relevance of annexin A3 in prostate cancer.

    1. Köllermann, Jens
    2. Schlomm, Thorsten
    3. Bang, Holger
    4. Schwall, Gerhard P
    5. von Eichel-Streiber, Christoph
    6. Simon, Ronald
    7. Schostak, Martin

    2008 - Forschungsinformationssystem des UKE
15. Marked gene transcript level alterations occur early during radical prostatectomy.

    1. Schlomm, Thorsten
    2. Näkel, Esther
    3. Lübke, Andreas
    4. Buness, Andreas
    5. Chun, Felix
    6. Steuber, Thomas
    7. Graefen, Markus

    2008 - Forschungsinformationssystem des UKE